NASDAQ
Altimmune, Inc. (ALT) reported revenue of $41.00K and net income of $-88,093,000 for FY 2025, with a net profit margin of -214861.0%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.